Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas
- PMID: 3014513
- PMCID: PMC323837
- DOI: 10.1073/pnas.83.13.4834
Genetic alteration of the c-myc protooncogene (MYC) in human primary breast carcinomas
Abstract
We have studied the genomic organization of the c-myc locus (MYC) from 121 human primary breast carcinomas. Two types of alterations were observed: (i) the c-myc protooncogene appeared to be amplified 2- to 15-fold in 38 (32%) of the carcinoma DNAs and (ii) a non-germ-line c-myc-related fragment of variable size was detected in 5 primary breast carcinoma DNAs. With three exceptions, all the tumors containing a genetic alteration of the c-myc locus were invasive ductal carcinomas. A significant correlation (P less than 0.02) was observed between patients more than 50 years old and the presence of a genetically altered c-myc. Enhanced levels of c-myc RNA were observed in 10 of 14 breast carcinomas examined. The c-myc gene was genetically altered in 6 of these 10 tumors. The frequency with which the c-myc gene is altered and its correlation with age suggest that it may play a role in the development of breast carcinomas.
Similar articles
-
Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.Cancer Res. 1989 Dec 1;49(23):6675-9. Cancer Res. 1989. PMID: 2573420
-
Alterations to either c-erbB-2(neu) or c-myc proto-oncogenes in breast carcinomas correlate with poor short-term prognosis.Oncogene. 1987;1(4):423-30. Oncogene. 1987. PMID: 3330785
-
In situ c-myc expression and genomic status of the c-myc locus in infiltrating ductal carcinomas of the breast.Cancer Res. 1988 Jan 1;48(1):199-205. Cancer Res. 1988. PMID: 2825967
-
The human breast carcinoma cell line SW 613-S: an experimental system to study tumor heterogeneity in relation to c-myc amplification, growth factor production and other markers (review).Anticancer Res. 1989 Sep-Oct;9(5):1265-79. Anticancer Res. 1989. PMID: 2686529 Review.
-
Oncogene amplification in tumor cells.Adv Cancer Res. 1986;47:235-81. doi: 10.1016/s0065-230x(08)60201-8. Adv Cancer Res. 1986. PMID: 3022564 Review. No abstract available.
Cited by
-
C-erbB2 mRNA expression in human breast tumours: comparison with c-erbB2 DNA amplification and correlation with prognosis.Br J Cancer. 1990 Jan;61(1):39-45. doi: 10.1038/bjc.1990.9. Br J Cancer. 1990. PMID: 2153396 Free PMC article.
-
Targeted c-myc gene expression in mammary glands of transgenic mice induces mammary tumours with constitutive milk protein gene transcription.EMBO J. 1988 Jan;7(1):169-75. doi: 10.1002/j.1460-2075.1988.tb02797.x. EMBO J. 1988. PMID: 2834201 Free PMC article.
-
Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression.Clin Mol Pathol. 1996 Feb;49(1):M46-50. doi: 10.1136/mp.49.1.m46. Clin Mol Pathol. 1996. PMID: 16696045 Free PMC article.
-
Whole genome DNA copy number changes identified by high density oligonucleotide arrays.Hum Genomics. 2004 May;1(4):287-99. doi: 10.1186/1479-7364-1-4-287. Hum Genomics. 2004. PMID: 15588488 Free PMC article.
-
Targeting oncogenic protein-protein interactions by diversity oriented synthesis and combinatorial chemistry approaches.Molecules. 2011 May 27;16(6):4408-27. doi: 10.3390/molecules16064408. Molecules. 2011. PMID: 21623312 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical